NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings
Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度股东会决议公告 | 2026-04-24 | Chinese | |
| 北京德恒律师事务所关于东北制药集团股份有限公司2025年度股东会的法律意见 | 2026-04-24 | Chinese | |
| 诉讼进展公告 | 2026-04-24 | Chinese | |
| 2025年度独立董事述职报告(黄永维) | 2026-04-02 | Chinese | |
| 2025年度独立董事述职报告(姚辉-已离任) | 2026-04-02 | Chinese | |
| 关于2025年度会计师事务所履职情况评估报告及董事会审计委员会履行监督职责情况报告 | 2026-04-02 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42679641 | 2025年度股东会决议公告 | 2026-04-24 | Chinese | ||
| 42679639 | 北京德恒律师事务所关于东北制药集团股份有限公司2025年度股东会的法律意见 | 2026-04-24 | Chinese | ||
| 42679628 | 诉讼进展公告 | 2026-04-24 | Chinese | ||
| 42679622 | 2025年度独立董事述职报告(黄永维) | 2026-04-02 | Chinese | ||
| 42679573 | 2025年度独立董事述职报告(姚辉-已离任) | 2026-04-02 | Chinese | ||
| 42679524 | 关于2025年度会计师事务所履职情况评估报告及董事会审计委员会履行监督职责情况报告 | 2026-04-02 | Chinese | ||
| 42679516 | 2025年度独立董事述职报告(刘兴明) | 2026-04-02 | Chinese | ||
| 42679479 | 2025年度独立董事述职报告(王国栋-已离任) | 2026-04-02 | Chinese | ||
| 42679439 | 关于公司2025年度计提资产减值准备的公告 | 2026-04-02 | Chinese | ||
| 42679409 | 关于公司及子公司2026年度金融机构授信总额度的公告 | 2026-04-02 | Chinese | ||
| 42679385 | 关于公司为下属子公司提供担保的公告 | 2026-04-02 | Chinese | ||
| 42679358 | 董事会关于对独立董事2025年度独立性的评估及专项意见 | 2026-04-02 | Chinese | ||
| 42679327 | 控股股东及其他关联方资金占用情况的专项说明 | 2026-04-02 | Chinese | ||
| 42678133 | 关于拟续聘公司2026年度审计机构的公告 | 2026-04-02 | Chinese | ||
| 42678098 | 2025年度独立董事述职报告(曹越) | 2026-04-02 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53700/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53700 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53700 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53700 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53700}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NORTHEAST PHARMACEUTICAL GROUP CO.,LTD (id: 53700)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.